Magdalena Ratajska
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 8
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 8
- Genetics top 10%
- BRCA gene mutations in cancer 15
-
- PARP inhibition in cancer therapy 5
-
- DNA Repair Mechanisms 8
- RNA Research and Splicing 6
- CRISPR and Genetic Engineering 5
- Genomics and Chromatin Dynamics 5
- Co-authors
- Janusz LimonPiotr KozłowskiIzabela BrożekMalwina SuszyńskaIrmgard Irminger‐FingerMaxim PilyuginWojciech BiernatMaciej Stukan
- Partner nations
- PolandNew ZealandSwitzerland
In The Last Decade
Magdalena Ratajska
33 papers receiving 645 citations
Peers
Comparison fields: 5 of 61
- Reproductive Medicine 115
- Cancer Research 189
- Genetics 339
- Oncology 206
- Pathology and Forensic Medicine 105
Countries citing papers authored by Magdalena Ratajska
This map shows the geographic impact of Magdalena Ratajska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Ratajska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Ratajska more than expected).
Fields of papers citing papers by Magdalena Ratajska
This network shows the impact of papers produced by Magdalena Ratajska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Ratajska. The network helps show where Magdalena Ratajska may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Magdalena Ratajska, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2022 | 22 | |
| 3 | 2021 | 4 | |
| 4 | 2021 | 5 | |
| 5 | 2020 | 69 | |
| 6 | 2019 | 6 | |
| 7 | ovarian cancer in a family with coexistence of germline nf1 and brca1 mutations case report | 2018 | 1 |
| 8 | 2016 | 9 | |
| 9 | 2015 | 24 | |
| 10 | 2015 | 15 | |
| 11 | 2015 | 58 | |
| 12 | 2015 | 8 | |
| 13 | 2014 | 18 | |
| 14 | 2012 | 20 | |
| 15 | 2011 | 71 | |
| 16 | 2011 | 2 | |
| 17 | 2010 | 10 | |
| 18 | 2009 | 7 | |
| 19 | 2007 | 44 | |
| 20 | 2006 | 3 |
About Magdalena Ratajska
Magdalena Ratajska is a scholar working on Reproductive Medicine, Genetics and Cancer Research, having authored 34 papers that have together received 654 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (15 papers), DNA Repair Mechanisms (8 papers), Ovarian cancer diagnosis and treatment (8 papers), Cancer Genomics and Diagnostics (8 papers), RNA Research and Splicing (6 papers), CRISPR and Genetic Engineering (5 papers), PARP inhibition in cancer therapy (5 papers) and Genomics and Chromatin Dynamics (5 papers). The work is most often cited by research in Reproductive Medicine (115 citations), Cancer Research (189 citations) and Genetics (339 citations). Magdalena Ratajska has collaborated with scholars based in Poland, New Zealand and Switzerland. Frequent co-authors include Janusz Limon, Piotr Kozłowski, Izabela Brożek, Malwina Suszyńska, Irmgard Irminger‐Finger, Maxim Pilyugin, Wojciech Biernat, Maciej Stukan, Magdalena Koczkowska and Åke Borg. Their work appears in journals such as PLoS ONE, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.